JPRN-UMIN000016934已完成未知
Clinical research on [-2] proPSA measurement in a diagnosis of prostate cancer: prostate health index trial. - Importance of [-2] proPSA measurement in a diagnosis of PROstate cancer: Prostate HEalth index Trial. (PROPHET).
Clinical Research Support Center Kyushu0 个研究点目标入组 300 人开始时间: 2015年3月27日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50years-old 至 79years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1) Patients with an apparent urinary tract infection. 2) Patients with an operation history of benign prostate hyperplasia. 3) Patients who are taking steroidal, non-steroidal anti-androgen, 5alpha-reductase inhibitor within 3 months. 4) Any other patients who are regarded as unsuitable for this study by the investigators.
研究者
相似试验
招募中
不适用
Clinical research on [-2] proPSA measurement in a diagnosis of prostate cancer: prostate health index trial. Side study: head to head comparison between [-2] proPSA-related indices and MRIprostate cancerJPRN-UMIN000047187Department of Urology, Gunma University Graduate School of Medicine109
招募中
2 期
Clinical significance of [-2]proPSA during active surveillance for localized prostate cancerprostate cancerJPRN-UMIN000009876Department of Urology, Kagawa University1,100
招募中
2 期
A phase II trial of docetaxel (Taxotere) in combination with PI88 for men with androgen independent prostate cancerACTRN1260700030740482
招募中
不适用
Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) for intermediate-high risk prostate cancer diagnosis: The SAMURAI TrialCancer - ProstateProstate CancerACTRN12618001307291Australian Urology Associates50
已完成
不适用
Clinical trial to research a novel biomarker of PSK responders in patients with colorectal cancercolorectal cancerJPRN-UMIN000010045Department of Digestive Surgery and Surgical Oncology, Yamaguchi University Graduate School of Medicine100